Latest News about MRK
Recent news which mentions MRK
From Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
November 30, 2021
From Benzinga
From Benzinga
Why Merck Stock Is Slipping Today
November 29, 2021
From Motley Fool
Merck stock dives after Citi downgrades on ‘high probability’ that HIV treatment will be abandoned
November 29, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
November 29, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
November 29, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
From Benzinga
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%
November 26, 2021
Tickers
MRK
From Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
From Benzinga
Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer
November 23, 2021
Tickers
MRK
From Benzinga
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
November 23, 2021
From Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
From Benzinga
Will Investors Benefit From Johnson & Johnson's Breakup?
November 23, 2021
From Motley Fool
Orally Administered Covid-19 Treatment Should Bolster Merck’s Value
November 22, 2021
Tickers
MRK
From InvestorPlace
3 Falling-Star Stocks to Buy Into the Holidays
November 22, 2021
From InvestorPlace
Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year
November 22, 2021
From InvestorPlace
From Motley Fool
Is Merck Stock a Buy?
November 20, 2021
From Motley Fool
EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness
November 19, 2021
Tickers
MRK
From Benzinga
Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention
November 19, 2021
From MarketWatch
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
From InvestorPlace
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
November 19, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.